VYGR Insider Transactions — Page 2
164 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 101–164; provenance stays internal.
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| TEPPER ROBERT I | TenPercentOwner | 2022-08-16 | Sale | 128,456.0 | $6.04 |
| Third Rock Ventures III, L.P. | TenPercentOwner | 2022-08-16 | Sale | 128,456.0 | $6.04 |
| TRV GP III, LLC | TenPercentOwner | 2022-08-16 | Sale | 128,456.0 | $6.04 |
| Third Rock Ventures GP III, L.P. | TenPercentOwner | 2022-08-16 | Sale | 128,456.0 | $6.04 |
| TEPPER ROBERT I | TenPercentOwner | 2022-08-15 | Sale | 135,808.0 | $6.04 |
| Third Rock Ventures III, L.P. | TenPercentOwner | 2022-08-15 | Sale | 135,808.0 | $6.04 |
| TRV GP III, LLC | TenPercentOwner | 2022-08-15 | Sale | 135,808.0 | $6.04 |
| Third Rock Ventures GP III, L.P. | TenPercentOwner | 2022-08-15 | Sale | 135,808.0 | $6.04 |
| TEPPER ROBERT I | TenPercentOwner | 2022-08-12 | Sale | 348,007.0 | $6.12 |
| Third Rock Ventures III, L.P. | TenPercentOwner | 2022-08-12 | Sale | 348,007.0 | $6.12 |
| TRV GP III, LLC | TenPercentOwner | 2022-08-12 | Sale | 348,007.0 | $6.12 |
| Third Rock Ventures GP III, L.P. | TenPercentOwner | 2022-08-12 | Sale | 348,007.0 | $6.12 |
| PIERCE GLENN | Director | 2022-07-14 | Sale | 9,512.0 | $6.7 |
| Higgins Michael J | Director | 2022-07-14 | Sale | 13,891.0 | $6.7 |
| EcoR1 Capital, LLC | TenPercentOwner | 2022-06-23 | Purchase | 376,000.0 | $5.66 |
| EcoR1 Capital, LLC | TenPercentOwner | 2022-06-21 | Purchase | 101,400.0 | $5.28 |
| Swartz Robin | Chief Operating Officer | 2022-04-04 | Sale | 1,527.0 | $8.25 |
| Hesslein Robert W. | Senior VP & General Counsel | 2022-04-04 | Sale | 2,786.0 | $8.25 |
| Swartz Robin | Chief Operating Officer | 2022-03-21 | Sale | 51.0 | $8.68 |
| Swartz Robin | Chief Operating Officer | 2022-03-21 | Sale | 4,362.0 | $8.29 |
| Hesslein Robert W. | Senior VP & General Counsel | 2022-03-21 | Sale | 58.0 | $8.68 |
| Hesslein Robert W. | Senior VP & General Counsel | 2022-03-21 | Sale | 4,897.0 | $8.29 |
| Burek Julie | VP, Finance | 2022-03-21 | Sale | 31.0 | $8.68 |
| Burek Julie | VP, Finance | 2022-03-21 | Sale | 2,618.0 | $8.29 |
| Hesslein Robert W. | Senior VP & General Counsel | 2022-02-17 | Sale | 4,100.0 | $3.55 |
| Burek Julie | VP, Finance | 2022-02-17 | Sale | 789.0 | $3.55 |
| Hesslein Robert W. | Senior VP & General Counsel | 2022-02-11 | Sale | 3,252.0 | $3.36 |
| Burek Julie | VP, Finance | 2022-02-11 | Sale | 361.0 | $3.36 |
| Burek Julie | VP, Finance | 2022-01-12 | Sale | 265.0 | $3.06 |
| Burek Julie | VP, Finance | 2022-01-03 | Sale | 3,063.0 | $2.83 |
| Khwaja Omar | See remarks | 2021-05-21 | Sale | 3,516.0 | $4.03 |
| Hesslein Robert W. | Senior VP & General Counsel | 2021-04-05 | Sale | 3,292.0 | $4.95 |
| Turenne Andre | President & CEO | 2021-02-11 | Sale | 7,977.0 | $7.55 |
| Dorval Allison | Chief Financial Officer | 2021-02-11 | Sale | 3,186.0 | $7.55 |
| Hesslein Robert W. | Senior VP & General Counsel | 2021-02-11 | Sale | 3,186.0 | $7.55 |
| Khwaja Omar | See remarks | 2021-02-11 | Sale | 3,475.0 | $7.55 |
| Turenne Andre | President & CEO | 2021-01-12 | Sale | 10,443.0 | $8.62 |
| Dorval Allison | Chief Financial Officer | 2021-01-12 | Sale | 2,942.0 | $8.62 |
| Khwaja Omar | See remarks | 2020-05-21 | Sale | 3,500.0 | $12.96 |
| Hesslein Robert W. | Senior VP & General Counsel | 2020-04-03 | Sale | 3,091.0 | $8.51 |
| Dorval Allison | Chief Financial Officer | 2020-01-21 | Sale | 3,128.0 | $13.36 |
| Ottmer Matthew P. | Chief Operating Officer | 2020-01-21 | Sale | 3,724.0 | $13.36 |
| Turenne Andre | President & CEO | 2020-01-21 | Sale | 10,705.0 | $13.36 |
| NEUROCRINE BIOSCIENCES INC | TenPercentOwner | 2019-03-12 | Purchase | 4,179,728.0 | $11.96 |
| PIERCE GLENN | Director | 2018-09-12 | Purchase | 5,000.0 | $18.44 |
| GERAGHTY JAMES A | Director | 2018-09-10 | Purchase | 3,000.0 | $19.39 |
| GERAGHTY JAMES A | Director | 2018-08-17 | Purchase | 3,000.0 | $18.31 |
| Ravina Bernard | Chief Medical Officer | 2018-04-10 | Sale | 2,451.0 | $18.38 |
| Henderson Jane | Sr. V.P. & CFO, Corp. Dev. | 2018-03-23 | Sale | 11,200.0 | $20.52 |
| Henderson Jane | Sr. V.P. & CFO, Corp. Dev. | 2018-03-22 | Sale | 19,900.0 | $21.07 |
| Henderson Jane | CFO & SVP, Corp. Dev. | 2018-03-19 | Sale | 1,900.0 | $21.76 |
| Henderson Jane | CFO & SVP, Corp. Dev. | 2018-03-16 | Sale | 15,416.0 | $22.15 |
| Ravina Bernard | Chief Medical Officer | 2018-03-12 | Sale | 2,451.0 | $25.16 |
| Sah Dinah Ph.D. | Chief Scientific Officer | 2018-02-27 | Sale | 15,623.0 | $30.0 |
| Ravina Bernard | Chief Medical Officer | 2018-02-12 | Sale | 2,451.0 | $18.24 |
| Ravina Bernard | Chief Medical Officer | 2018-01-10 | Sale | 3,630.0 | $16.4 |
| Ravina Bernard | Chief Medical Officer | 2017-12-11 | Sale | 5,490.0 | $13.63 |
| Ravina Bernard | Chief Medical Officer | 2017-11-10 | Sale | 5,490.0 | $13.26 |
| Ravina Bernard | Chief Medical Officer | 2017-10-10 | Sale | 10,980.0 | $20.33 |
| Ravina Bernard | Chief Medical Officer | 2017-09-11 | Sale | 10,980.0 | $14.3 |
| Ravina Bernard | Chief Medical Officer | 2017-09-05 | Sale | 5,490.0 | $10.0 |
| Ravina Bernard | Chief Medical Officer | 2017-07-20 | Sale | 5,490.0 | $10.0 |
| PAUL STEVEN M | President and CEO | 2016-01-14 | Purchase | 10,000.0 | $14.07 |
| Sanofi | Other | 2015-11-16 | Purchase | 125,000.0 | $14.0 |